High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes. - Suppr | 超能文献

High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes.

作者信息

Richart Adele L, Heywood Sarah E, Siebel Andrew L, Kingwell Bronwyn A

机构信息

1 Baker Heart and Diabetes Institute, Melbourne, Australia.

2 Department of Physiology, University of Melbourne, Australia.

出版信息

Eur J Prev Cardiol. 2018 Feb;25(3):273-275. doi: 10.1177/2047487317748217. Epub 2017 Dec 14.

DOI:10.1177/2047487317748217

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes.

Eur J Prev Cardiol. 2018 Feb;25(3):273-275. doi: 10.1177/2047487317748217. Epub 2017 Dec 14.

2

Acute coronary syndromes: Myocardial salvage with HDL infusion after infarction.急性冠状动脉综合征：心肌梗死后输注高密度脂蛋白进行心肌挽救。

Nat Rev Cardiol. 2017 Dec;14(12):695. doi: 10.1038/nrcardio.2017.168. Epub 2017 Oct 26.

3

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.急性冠状动脉综合征中高密度脂蛋白和低密度脂蛋白的治疗方法

Curr Cardiol Rev. 2017;13(3):168-182. doi: 10.2174/1573403X13666170209145622.

4

Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome.促氧化剂 HDL 可预测 ST 段抬高型急性冠状动脉综合征患者的不良预后。

Thromb Haemost. 2015 Jul;114(1):133-8. doi: 10.1160/TH14-10-0834. Epub 2015 Apr 2.

5

Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.非ST段抬高型急性冠脉综合征患者低密度高密度脂蛋白水平的模式及预后意义

Eur Heart J. 2008 Oct;29(20):2480-8. doi: 10.1093/eurheartj/ehn364. Epub 2008 Aug 20.

6

Thrombophilic state in young patients with acute myocardial infarction.年轻急性心肌梗死患者的血栓形成倾向状态

J Thromb Thrombolysis. 2015 May;39(4):474-80. doi: 10.1007/s11239-014-1166-2.

7

The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.在急性冠脉综合征中，高密度脂蛋白的抗氧化能力降低，但在稳定型冠状动脉疾病中则不会。

J Am Coll Cardiol. 2011 Nov 8;58(20):2068-75. doi: 10.1016/j.jacc.2011.08.030.

8

The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.急性冠状动脉综合征后胆固醇酯转移蛋白抑制对血脂、脂蛋白和高密度脂蛋白功能标志物的影响：dal-ACUTE 随机试验。

Eur Heart J. 2014 Jul 14;35(27):1792-800. doi: 10.1093/eurheartj/ehu105. Epub 2014 Mar 17.

9

Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.血浆 vaspin 浓度在急性冠状动脉综合征中降低，但在无冠状动脉病变的患者中不变。

Clin Biochem. 2013 Oct;46(15):1520-5. doi: 10.1016/j.clinbiochem.2013.06.028. Epub 2013 Jul 11.

10

Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.在阿拉伯急性冠脉综合征患者中，体重和致动脉粥样硬化性血脂异常是 B 型利钠肽血水平的主要决定因素。

Metab Syndr Relat Disord. 2009 Dec;7(6):563-9. doi: 10.1089/met.2009.0034.

引用本文的文献

1

Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death.通过miR-34a和miR-125b抑制葡萄糖代谢可预防高血糖诱导的心肌细胞死亡。

Arq Bras Cardiol. 2021 Mar;116(3):415-422. doi: 10.36660/abc.20190529.